Serum levels of GM-CSF, CCL11, CCL22 and TRAIL in patients with primary ST-segment elevation myocardial infarction and post-infarction heart remodeling

A. M. Nikolaeva; I. V. Kologrivova; T. R. Ryabova; V. V. Ryabov; T. E. Suslova

Siberian Journal of Clinical and Experimental Medicine

ISSN 2713-2927 (Print)
ISSN 2713-265X (Online)

User

eng | рус

Siberian Journal of Clinical and Experimental Medicine

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Nikolaeva A.M., Kologrivova I.V., Ryabova T.R., Ryabov V.V., Suslova T.E. Serum levels of GM-CSF, CCL11, CCL22 and TRAIL in patients with primary ST-segment elevation myocardial infarction and post-infarction heart remodeling. Siberian Journal of Clinical and Experimental Medicine. 2023;38(2):104-113. (In Russ.) https://doi.org/10.29001/2073-8552-2023-38-2-104-113

Views PDF (Rus): 338

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2713-2927 (Print)
ISSN 2713-265X (Online)

Internal Medicine

Radiology, Nuclear Medicine and Imaging

Medicine (miscellaneous)

Notifications

* not an advertisement

Indexing Databases

* not an advertisement

Editor-in-Chief

Rostislav S. Karpov

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

A. M. Nikolaeva
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation

Antonina M. Nikolaeva - Graduate Student, Department of Emergency Cardiology